Dipyridyl

Dipyridyl

SCHEMBL701722

Cc1ccnc(-c2cc(CCCCN)ccn2)c1.[Ru].c1ccc(-c2ccccn2)nc1.c1ccc(-c2ccccn2)nc1

nearest known ligand 0.45

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CCR1 P32246 2/20 0.45
CCR5 P51681 2/20 0.45
CCR8 P51685 2/20 0.45
HRH1 P35367 5/20 0.43
SIGMAR1 Q99720 1/20 0.40
KARS1 Q15046 2/20 0.40
FAAH O00519 1/20 0.39
CES1 P23141 1/20 0.39
MAOA P21397 1/20 0.39
KCNN1 Q92952 1/20 0.38
KCNN2 Q9H2S1 1/20 0.38
KCNN3 Q9UGI6 1/20 0.38
HPGD P15428 1/20 0.38
NPSR1 Q6W5P4 1/20 0.38
SLC2A1 P11166 1/20 0.38
KDM4E B2RXH2 1/20 0.37
LMNA P02545 1/20 0.37
CYP1A2 P05177 1/20 0.37
POLB P06746 1/20 0.37
METAP1 P53582 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Dipyridyl SCHEMBL5004969 1.00 CCR1 (0.45) CCR1CCR5CCR8HRH1SIGMAR1
Dipyridyl SCHEMBL1318097 0.99 CCR1 (0.46) CCR1CCR5CCR8HRH1SIGMAR1
Dipyridyl SCHEMBL1923113 0.99 CCR1 (0.46) CCR1CCR5CCR8HRH1SIGMAR1
SCHEMBL6699910 0.92 CCR1 (0.53) CCR1CCR5CCR8HRH1KARS1
Dipyridyl SCHEMBL3126694 0.92 CCR1 (0.40) CCR1CCR5CCR8HRH1SIGMAR1
SCHEMBL6494641 0.90 CCR1 (0.55) CCR1CCR5CCR8HRH1KARS1
Dipyridyl SCHEMBL699785 0.87 CCR1 (0.45) CCR1CCR5CCR8SIGMAR1FAAH
Dipyridyl SCHEMBL5007665 0.87 CCR1 (0.45) CCR1CCR5CCR8SIGMAR1FAAH
SCHEMBL7039186 0.86 CCR1 (0.57) CCR1CCR5CCR8HRH1KARS1
Dipyridyl SCHEMBL8658875 0.85 CCR1 (0.46) CCR1CCR5CCR8SIGMAR1FAAH

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 185 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7247375-B2 Polymeric matrices for the encapsulation of phosphorescent molecules for analytical applications KIMBERLY-CLARK WORLDWIDE, INC. (US) 2007-07-24 US claimed
WO-2005111174-A1 POLYMERIC MATRICES FOR THE ENCAPSULATION OF PHOSPHORESCENT MOLECULES FOR ANALYTICAL APPLICATIONS KIMBERLY-CLARK WORLDWIDE, INC. (US) 2005-11-24 WO claimed
US-20050244643-A1 Polymeric matrices for the encapsulation of phosphorescent molecules for analytical applications KIMBERLY-CLARK WORLDWIDE, INC. 2005-11-03 US claimed
US-6132955-A Method for derivitizing electrodes and assay methods using such derivitized electrodes IGEN INTERNATIONAL, INC. (US) 2000-10-17 US claimed
EP-0265519-B1 ELECTROCHEMILUMINESCENT ASSAYS IGEN INC (US) 1995-09-13 EP claimed
EP-0265519-A4 ELECTROCHEMILUMINESCENT ASSAYS. IGEN INC (US) 1990-05-14 EP claimed
EP-0265519-A1 ELECTROCHEMILUMINESCENT ASSAYS. IGEN INC (US) 1988-05-04 EP claimed
WO-1987006706-A1 ELECTROCHEMILUMINESCENT ASSAYS IGEN, INC. (US) 1987-11-05 WO claimed
US-20240201190-A1 COMPOSITIONS AND METHODS OF DIAGNOSING PANCREATIC CANCER THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2024-06-20 US disclosed
WO-2023240247-A9 COMPOSITIONS FOR AND METHODS OF DETECTING FOOD TOXINS THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2024-04-25 WO disclosed
US-20240044804-A9 BRANCHED-CHAIN AMINES IN ELECTROCHEMILUMINESCENCE DETECTION ROCHE DIAGNOSTICS OPERATIONS, INC. 2024-02-08 US disclosed
WO-2023240247-A2 COMPOSITIONS FOR AND METHODS OF DETECTING FOOD TOXINS THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2023-12-14 WO disclosed
US-11726091-B2 Compositions and methods of diagnosing pancreatic cancer THE REGENTS OF THE UNIVERSITY OF CALIFORNIA 2023-08-15 US disclosed
US-20230174912-A1 SYSTEM, DEVICE, AND METHOD FOR SINGLE-CELL ENCAPSULATION AND CULTURE UNIVERSITY OF MARYLAND, COLLEGE PARK 2023-06-08 US disclosed
EP-0265519-B1 ELECTROCHEMILUMINESCENT ASSAYS IGEN INC (US) 1995-09-13 EP disclosed
EP-0658564-A1 Electroluminescent compounds and intermediates in their synthesis IGEN, INC. (US) 1995-06-21 EP disclosed
EP-0647849-A2 Detecting the presence of analytes in a sample IGEN, INC. (US) 1995-04-12 EP disclosed
EP-0265519-A4 ELECTROCHEMILUMINESCENT ASSAYS. IGEN INC (US) 1990-05-14 EP disclosed
EP-0265519-A1 ELECTROCHEMILUMINESCENT ASSAYS. IGEN INC (US) 1988-05-04 EP disclosed
WO-1987006706-A1 ELECTROCHEMILUMINESCENT ASSAYS IGEN, INC. (US) 1987-11-05 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240044804-A9 BRANCHED-CHAIN AMINES IN ELECTROCHEMILUMINESCENCE DETECTION BCAT2, BCAT1, MAOB CCR1 4138/4885CCR5 1706/4885CCR8 3254/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.